List of Excipients in API alpelisib
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing alpelisib
Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
---|---|---|---|---|---|
Novartis Pharmaceuticals Corporation | PIQRAY | alpelisib | 0078-0708 | CELLULOSE, MICROCRYSTALLINE | 2033-04-29 |
Novartis Pharmaceuticals Corporation | PIQRAY | alpelisib | 0078-0708 | FERRIC OXIDE RED | 2033-04-29 |
Novartis Pharmaceuticals Corporation | PIQRAY | alpelisib | 0078-0708 | FERROSOFERRIC OXIDE | 2033-04-29 |
Novartis Pharmaceuticals Corporation | PIQRAY | alpelisib | 0078-0708 | HYPROMELLOSE | 2033-04-29 |
Novartis Pharmaceuticals Corporation | PIQRAY | alpelisib | 0078-0708 | MAGNESIUM STEARATE | 2033-04-29 |
>Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for alpelisib
Excipient focus: CELLULOSE, MICROCRYSTALLINE
alpelisib drug variants containing CELLULOSE, MICROCRYSTALLINE
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | alpelisib | 0078-0708 |
Novartis Pharmaceuticals Corporation | alpelisib | 0078-1021 |
>Company | >Ingredient | >NDC |
alpelisib drug variants not containing CELLULOSE, MICROCRYSTALLINE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE RED
alpelisib drug variants containing FERRIC OXIDE RED
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | alpelisib | 0078-0708 |
Novartis Pharmaceuticals Corporation | alpelisib | 0078-1021 |
>Company | >Ingredient | >NDC |
alpelisib drug variants not containing FERRIC OXIDE RED
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE YELLOW
alpelisib drug variants containing FERRIC OXIDE YELLOW
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | alpelisib | 0078-1021 |
>Company | >Ingredient | >NDC |
alpelisib drug variants not containing FERRIC OXIDE YELLOW
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | alpelisib | 0078-0708 |
>Company | >Ingredient | >NDC |
Excipient focus: FERROSOFERRIC OXIDE
alpelisib drug variants containing FERROSOFERRIC OXIDE
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | alpelisib | 0078-0708 |
>Company | >Ingredient | >NDC |
alpelisib drug variants not containing FERROSOFERRIC OXIDE
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | alpelisib | 0078-1021 |
>Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE
alpelisib drug variants containing HYPROMELLOSE
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | alpelisib | 0078-0708 |
Novartis Pharmaceuticals Corporation | alpelisib | 0078-1021 |
>Company | >Ingredient | >NDC |
alpelisib drug variants not containing HYPROMELLOSE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
alpelisib drug variants containing MAGNESIUM STEARATE
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | alpelisib | 0078-0708 |
Novartis Pharmaceuticals Corporation | alpelisib | 0078-1021 |
>Company | >Ingredient | >NDC |
alpelisib drug variants not containing MAGNESIUM STEARATE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: MANNITOL
alpelisib drug variants containing MANNITOL
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | alpelisib | 0078-0708 |
Novartis Pharmaceuticals Corporation | alpelisib | 0078-1021 |
>Company | >Ingredient | >NDC |
alpelisib drug variants not containing MANNITOL
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 4000
alpelisib drug variants containing POLYETHYLENE GLYCOL 4000
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | alpelisib | 0078-0708 |
Novartis Pharmaceuticals Corporation | alpelisib | 0078-1021 |
>Company | >Ingredient | >NDC |
alpelisib drug variants not containing POLYETHYLENE GLYCOL 4000
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO
alpelisib drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | alpelisib | 0078-0708 |
Novartis Pharmaceuticals Corporation | alpelisib | 0078-1021 |
>Company | >Ingredient | >NDC |
alpelisib drug variants not containing SODIUM STARCH GLYCOLATE TYPE A POTATO
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: TALC
alpelisib drug variants containing TALC
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | alpelisib | 0078-0708 |
Novartis Pharmaceuticals Corporation | alpelisib | 0078-1021 |
>Company | >Ingredient | >NDC |
alpelisib drug variants not containing TALC
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
alpelisib drug variants containing TITANIUM DIOXIDE
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | alpelisib | 0078-0708 |
Novartis Pharmaceuticals Corporation | alpelisib | 0078-1021 |
>Company | >Ingredient | >NDC |
alpelisib drug variants not containing TITANIUM DIOXIDE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.